title: [Infiltrating transitional carcinoma of the bladder (4). Our approach to stage pT2 and critique of other risk factors. Multifactorial analysis].
abstract: From the analysis of our experience with pT2 and pT3a tumours it could be deduced that the former have better prognosis. The papillary appearance, invasion in a wide front and extent, whether with good or moderate differentiation, in T2 are signs of good prognosis, as well as the non-existence of unilateral dilation or an effaced kidney. Considering the good evolution obtained with radical cystectomy only, these patients should be recruited for study in order to see whether evolution with bladder preservation is similar. Patients with pT2 tumours should not be included in protocols to evaluate the efficacy of adjuvant therapies used with surgery. The evolution is not equivalent to that expected in tumours of deeper invasion.
authors.affiliation: Servicio de Urología, Hospital Ramón y Cajal., Madrid.
authors.forename: A
authors.initials: A
authors.lastname: Escudero Barrilero
authors.forename: L
authors.initials: L
authors.lastname: Perales
authors.forename: J
authors.initials: J
authors.lastname: Romero
authors.forename: J M
authors.initials: JM
authors.lastname: Rodríguez Luna
authors.forename: J
authors.initials: J
authors.lastname: Vallejo
authors.forename: J A
authors.initials: JA
authors.lastname: Rivas
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D002454:Cell Differentiation; D003131:Combined Modality Therapy; D015653:Cystectomy; D006801:Humans; D015993:Life Tables; D008197:Lymph Node Excision; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Carcinoma transicional infiltrante de vejiga. (4a parte). Nuestra actitud frente al estadio pT2 y crítica de otros factores de riesgo. Análisis multifactorial.